The Life Sciences Sector sources and supplies technology-driven, value-add solutions across the in vitro diagnostics, scientific and medtech segments of the global healthcare market.
FY 2024 Revenue
£ 221.9 m
FY23: £212.9m | +4% YoY
FY24 adjusted operating margin
21.1 %
FY23: 20.3% | +80bps
Colleagues
450 +
Our Life Sciences businesses typically operate in fragmented markets providing an effective route into markets which would otherwise be unviable for manufacturers to service. For customers, we serve as a trusted long-term partner providing access to a broad portfolio and pipeline of cutting-edge healthcare solutions, ultimately delivering improved patient care.
Customers benefit from technical product knowledge, clinical expertise, consultative support, training and technical support, regulatory assistance and equipment maintenance.
Our Life Sciences North America businesses - Somagen Diagnostics, AMT Surgical and Vantage Endoscopy - deliver advanced diagnostics technologies, allowing for early disease detection and monitory, and innovative surgical instruments and medical devices, specialising in endoscopes.
A journey to scale